Consolidation therapy with weekly paclitaxel infusion in advanced epithelial ovarian cancer and primary peritoneal cancer: An extended follow-up

Gynecologic Oncology

Volumn 98, Issue 1, 2005, Pages 59-62

  Skinner, Elizabeth N ^a   Boruta, David M ^b   Gehrig, Paola A ^a   Boggess, John F ^a   Fowler Jr , Wesley C ^a   Van Le, Linda ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Chemotherapy; Consolidation; Ovarian cancer; Paclitaxel

Indexed keywords

PACLITAXEL;

ADVANCED CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONSTIPATION; DOSE CALCULATION; DRUG CYTOTOXICITY; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG INFUSION; DRUG TOLERABILITY; FOLLOW UP; HUMAN; HYPERSENSITIVITY REACTION; MEDICAL ASSESSMENT; MEDICAL DOCUMENTATION; MEDICAL RECORD; NEUTROPENIA; OVARY CARCINOMA; PERIPHERAL NEUROPATHY; PERITONEUM CANCER; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; THROMBOCYTOPENIA;

EID: 20444470006     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.04.004     Document Type: Article

References (16)

1. A. Jemal, R.C. Tiwari, and T. Murray Cancer statistics, 2004 CA Cancer J. Clin. 54 2004 8 29
2. W.P. McGuire, W.J. Hoskins, and M.F. Brady Cyclophosphamide compared with paclitaxel and cisplatin in patients with stage III and IV ovarian cancer N. Engl. J. Med. 334 1996 1 6
3. R.F. Ozols, B.N. Bundy, and B.E. Greer Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study J. Clin. Oncol. 21 2003 3194 3200
4. A. du Bois, H.J. Luck, and W. Meier A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer J. Natl. Cancer Inst. 95 2003 1320 1330
5. D. Fennelly, C. Aghajanian, and F. Shapiro Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer J. Clin. Oncol. 15 1997 187 192
6. F. Pettersson Annual Report on the Results of Treatment in Gynecologic Cancer, FIGO 1994 1994 International Federation of Gynecology and Obstetrics Stockholm 83 102
7. B. Sorbe Consolidation treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: a randomized, controlled, clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatment Int. J. Gynecol. Cancer 13 3 2003 278 286
8. C. Tournigand, C. Louvet, and J.L. Molitor Long-term survival with consolidation intraperitoneal chemotherapy for patients with advanced ovarian cancer with pathological complete remission Gynecol. Oncol. 91 2 2003 341 345
9. H. Goldberg, M.E. Stein, M. Steiner, E. Sprecher, D. Beck, and A. Kuten Consolidation radiation therapy following cytoreductive surgery, chemotherapy and second-look laparotomy for epithelial ovarian carcinoma: long-term follow-up Tumori 87 4 2001 248 251
10. M.L. Rothenberg, P.Y. Liu, and S. Wilczynski Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326) Gynec. Oncol. 82 2001 317 322
11. M. Markman, P.Y. Liu, and S. Wilczynski Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a Southwest Oncology Group and Gynecologic Oncology Group trial J. Clin. Oncol. 21 2003 2460 2465
12. N.R. Abu-Rustum, C. Aghajanian, R.R. Barakat, D. Fennelly, F. Shapiro, and D. Spriggs Salvage weekly paclitaxel in recurrent ovarian cancer Semin Oncol. 24 5 Suppl. 15 1997 S1562 S1567
13. U. Klaasen, H. Wilke, D. Srumberg, A.W. Eberhardt, M. Korn, and S. Seeber Phase I study of weekly 1 h infusion of paclitaxel in heavily pretreated patients with metastatic breast and ovarian cancer Eur. J. Cancer 32A 3 1996 547 549
14. P. Rosenberg, H. Andersson, and K. Boman Randomized trial of single agent paclitaxel given weekly versus every three weeks and with preoral versus intravenous steroid premedication to patients with ovarian cancer previously treated with platinum Acta Oncol. 41 5 2002 418 424
15. M.J. Piccart, K. Bertelsen, and K. James Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced ovarian cancer: three year results J. Natl. Cancer Inst. 92 2000 699 708
16. F.M. Muggia, P.S. Braly, and M.F. Brady Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III and IV ovarian cancer: a Gynecologic Oncology Group study J. Clin. Oncol. 18 2000 106 115